While Berkshire Hathaway’s $28 billion acquisition of H.J. Heinz and the $11 billion merger between American Airlines and US Airways may have stolen the transactional spotlight Thursday, Cardinal Health, the nation’s second-largest drug wholesaler, announced a big deal of its own on Thursday: the $2.1 billion acquisition of home health care delivery products provider AssuraMed.
Paul Bird, cochair of Debevoise & Plimpton’s corporate department and M&A group, is advising AssuraMed on the sale along with employee benefits partner Jonathan Lewis, private equity partner Kevin Rinker, and tax partner David Schnabel.
